Form 4 for CLX Clorox
Accepted 2022-09-15 00:00:00 ET · period of report 2022-09-13 · accession 0001225208-22-010353 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-15 | 2022-09-13 | CLX | Ott Michael M | SVP - Chief Research, Dev Off | A - Grant | $144.00 | +322 | 4,340 | +8% | +$46.4K | |
| M | 2022-09-15 | 2022-09-13 | CLX | Ott Michael M | SVP - Chief Research, Dev Off | F - Tax | $144.00 | -236 | 4,228 | -5% | -$34.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-13 | A | A | 322 | $144.00 | 4,340 | D | — | — | |
| 2 | Common | Common Stock | 2022-09-13 | F | D | 124 | $144.00 | 4,104 | D | — | — | (F4) Includes 39 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. |
| 3 | Common | Common Stock | 2022-09-13 | F | D | 112 | $144.00 | 4,228 | D | — | — |